How scientists are stopping cavities without a drill, using a simple liquid

For most of dental history, treating a cavity has meant the same basic sequence regardless of the patient's age: numb the area, drill out the decayed tissue, and fill the resulting hole. For small children, that sequence is often the hardest part of the visit — not the decay itself, but the anxiety, and in some cases the need for sedation, that drilling requires in a child too young to sit still through a needle and a drill. A major US clinical trial has now added weight to a very different approach: a liquid called silver diamine fluoride, painted directly onto the decayed tooth surface in seconds, with no drilling, no injection and no sedation required.
The compound itself is not new. Silver diamine fluoride, often abbreviated SDF, has been used in some countries for decades and was approved in the US primarily as a treatment for tooth sensitivity before dentists began using it off-label to arrest decay. What the new trial adds is a rigorous, large-scale test of how well it actually works as a frontline treatment for cavities in baby teeth, rather than relying on smaller studies or accumulated clinical experience.
The mechanism is straightforward: silver has antimicrobial properties that kill the bacteria driving the decay process, while the fluoride component helps re-mineralise and harden the remaining tooth structure. Applied directly to a cavity with a small brush, the liquid penetrates the softened, decayed dentin and effectively halts its progression, sealing off the bacteria that would otherwise continue eating into the tooth.
According to the trial's findings, more than half of the baby teeth treated with SDF saw their decay successfully arrested, meaning the cavity stopped progressing without any drilling or restorative filling. That is a meaningful result for a population — very young children — where restorative dental treatment often requires either physical restraint, sedation or, in more severe cases, general anaesthesia, each of which carries its own costs, risks and logistical burden for families.
The tradeoff is cosmetic rather than functional: SDF permanently stains the treated area of the tooth a dark grey or black colour, a visible mark that lasts as long as the decay remains arrested. For a back molar this is rarely noticeable in daily life, but for a visible front tooth, the staining is a genuine consideration parents weigh against the benefits of avoiding drilling in a very young child.
Dentists who use the treatment describe it as particularly well suited to specific situations: very young children who cannot yet tolerate a drill-based procedure, children with high anxiety or additional needs that make traditional dental treatment especially difficult, and cases where a baby tooth is close enough to natural exfoliation that a full restorative filling is not worth the intervention. It is generally viewed as a way to buy time and arrest damage, sometimes as a bridge to eventual restorative treatment once a child is older and can better tolerate it.
Public health researchers see a broader application beyond individual dental practices: SDF's speed, low cost and minimal equipment requirements make it attractive for reaching children who otherwise have poor access to dental care, including in school-based screening programmes and underserved communities where a full restorative dental visit, with its need for specialised equipment and often sedation staff, is simply not available. A treatment that a trained provider can apply with a brush in a school nurse's office represents a meaningfully lower barrier than one requiring a fully equipped operatory.
Critics and cautious dentists note that SDF is not a universal substitute for restorative treatment. It works by halting the progression of decay rather than repairing tooth structure that has already been lost, so a badly cavitated tooth may still eventually need a filling or crown, particularly if it needs to function for years before natural loss. SDF is best understood as an intervention that prevents a small problem from becoming an emergency, not a replacement for restorative dentistry in every case.
Parent acceptance has grown steadily as the treatment has become more widely available, according to the researchers involved in the trial, particularly once the staining tradeoff is explained clearly upfront rather than discovered as a surprise after treatment. Clinics that offer both options — traditional filling or SDF — report that many parents choose SDF specifically for young or anxious children, reserving traditional restorative treatment for cases where cosmetic appearance matters more or the tooth requires structural repair regardless.
The trial's authors say the results support wider adoption of SDF as a standard, evidence-based option in paediatric dentistry rather than a niche or last-resort treatment, particularly for reaching the large number of young children who currently receive no dental care for early-stage cavities until the decay has progressed far enough to require far more invasive treatment. For a problem that has traditionally required a needle and a drill, the trial's central finding, that a liquid and a small brush stopped decay in more than half of cases, marks a meaningful shift in how a very old disease can be treated in the youngest patients.
Read next

England on track for record heat deaths this summer as UKHSA reports nearly 2,900 fatalities
The UK Health Security Agency estimates 2,877 people died during heatwaves in May and June alone, almost double the same period last year, putting England on course to exceed its all-time record of 2,985 heat deaths with August, historically the hottest month, still to come.

4 tips for choosing a hobby that actually improves your health
Doctors in some health systems now formally 'prescribe' hobbies alongside medication, part of a growing social-prescribing movement. Here is what research says makes a hobby actually beneficial, rather than just another item on a to-do list.

Why is syphilis surging again? A border-city case study explains the drug shortage behind it
Syphilis cases have been climbing for years across the United States, and clinicians on the San Diego-Tijuana border say a persistent shortage of the standard antibiotic, benzathine penicillin, is making the resurgence far harder to contain. A closely tracked patient case illustrates how supply gaps translate into real delays in treatment.

Novo Nordisk's inflammation drug ziltivekimab misses the mark in heart disease trial
Novo Nordisk's experimental antibody ziltivekimab, designed to lower cardiovascular risk by targeting inflammation rather than cholesterol, failed to significantly reduce major cardiac events in a large late-stage trial. The result is a setback for the broader theory that inflammation is an independent, treatable driver of heart attacks and strokes.

What your reading list reveals about your mind, according to psychologists
The books people reach for on holiday are rarely random: psychologists say reading choices track mood, stress levels and even how someone processes change. Researchers who study 'bibliotherapy' say the pattern is consistent enough to be useful.